GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TaiMed Biologics 4147.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

60.50

+10.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 611.4m

FY2016FY2025

Net income

−TWD 167.8m

FY2016FY2025

Free cash flow

TWD 168.4m

FY2016FY2025

Shareholders' equity

TWD 3.86bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 611.4mTWD 610.2mTWD 491.8mTWD 563.0mTWD 413.4mTWD 722.5mTWD 704.5mTWD 241.0mTWD 8.4mTWD 2.1m
Research and developmentTWD 381.8mTWD 388.2mTWD 294.3mTWD 333.1mTWD 460.6mTWD 394.4mTWD 575.8mTWD 440.4mTWD 510.7mTWD 276.6m
Operating income−TWD 194.6m−TWD 252.3m−TWD 188.4m−TWD 263.5m−TWD 486.4m−TWD 132.8m−TWD 390.0m−TWD 320.8m−TWD 545.2m−TWD 312.9m
Net income−TWD 167.8m−TWD 201.8m−TWD 194.8m−TWD 269.3m−TWD 470.9m−TWD 183.3m−TWD 578.7m−TWD 321.7m−TWD 524.6m−TWD 282.0m
Diluted earnings per share-0.61-0.74-0.76-1.07-1.87-0.73-2.29-1.28-2.10-3.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 4.81bnTWD 5.00bnTWD 3.89bnTWD 4.10bnTWD 4.61bnTWD 5.20bnTWD 4.73bnTWD 4.79bnTWD 4.50bnTWD 4.80bn
Total liabilitiesTWD 953.1mTWD 976.3mTWD 1.33bnTWD 1.39bnTWD 1.67bnTWD 1.78bnTWD 1.14bnTWD 710.6mTWD 210.7mTWD 88.0m
DebtTWD 440.2mTWD 522.6mTWD 750.9mTWD 766.1mTWD 567.3mTWD 569.3mTWD 34.0m———
Shareholders' equityTWD 3.86bnTWD 4.02bnTWD 2.57bnTWD 2.71bnTWD 2.94bnTWD 3.42bnTWD 3.59bnTWD 4.08bnTWD 4.29bnTWD 4.71bn
Shares outstanding273m273m257m253m252m252m252m251m250m88m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 191.1m−TWD 379.6m−TWD 25.6m−TWD 605.2m−TWD 211.3m−TWD 201.9m−TWD 655.3m−TWD 522.9m−TWD 516.5m−TWD 172.3m
Capital spending−TWD 22.8m−TWD 19.4m−TWD 6.2m−TWD 3.6m−TWD 9.7m−TWD 53.6m−TWD 121.5m−TWD 846.4m−TWD 278.1m−TWD 10.0m
Free cash flowTWD 168.4m−TWD 398.9m−TWD 31.8m−TWD 608.8m−TWD 221.0m−TWD 255.6m−TWD 776.9m−TWD 1.37bn−TWD 794.6m−TWD 182.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 155.8mTWD 166.1mTWD 149.9mTWD 147.7mTWD 137.5mTWD 176.2mTWD 145.8mTWD 138.5m
Operating income−TWD 74.7mTWD 2.3m−TWD 87.5m−TWD 27.7m−TWD 46.2m−TWD 33.3m−TWD 128.5m−TWD 45.4m
Net income−TWD 72.7mTWD 16.4m−TWD 68.5m−TWD 14.0m−TWD 59.5m−TWD 25.8m−TWD 120.5m−TWD 37.8m
Diluted earnings per share-0.270.06-0.25-0.05-0.22-0.09-0.44-0.14
Cash from operationsTWD 58.0m−TWD 45.0mTWD 25.0mTWD 115.0mTWD 4.0mTWD 45.0m−TWD 507.0mTWD 51.0m
Capital spending−TWD 26.0m−TWD 4.0m−TWD 16.0m—−TWD 1.0m−TWD 3.0m−TWD 1.0m−TWD 8.0m
Free cash flowTWD 32.0m−TWD 49.0mTWD 9.0m—TWD 3.0mTWD 42.0m−TWD 508.0mTWD 43.0m
Total assetsTWD 4.50bnTWD 4.63bnTWD 4.81bnTWD 4.82bnTWD 4.80bnTWD 4.93bnTWD 5.00bnTWD 5.73bn
DebtTWD 426.0mTWD 433.1mTWD 440.2mTWD 447.2mTWD 454.2mTWD 461.1mTWD 468.0mTWD 474.9m
Shareholders' equityTWD 3.68bnTWD 3.80bnTWD 3.86bnTWD 3.92bnTWD 3.92bnTWD 4.01bnTWD 4.02bnTWD 4.15bn

Financial ratios

Data as of 1 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-31.8%-41.3%-38.3%-46.8%-117.6%-18.4%—
Net margin-27.4%-33.1%-39.6%-47.8%-113.9%-25.4%—
Return on equity-4.3%-5.0%-7.6%-9.9%-16.0%-5.4%—
Return on assets-3.5%-4.0%-5.0%-6.6%-10.2%-3.5%—
Free cash flow yield—-2.1%-0.1%-3.8%-1.3%-0.9%-3.4%
Revenue growth0.2%24.1%-12.7%36.2%-42.8%2.6%—
Earnings growth-16.9%3.6%-27.7%-42.8%156.9%-68.3%—
Current ratio13.11x25.18x5.96x6.56x10.37x6.02x—
Debt to equity0.11x0.12x0.19x0.19x0.18x0.16x—
Equity ratio80.2%80.5%65.9%66.2%63.8%65.7%—
Interest coverage-18.17x-20.01x-12.72x-26.09x-65.34x-32.48x—
R&D as a share of sales62.5%63.6%59.8%59.2%111.4%54.6%—
Buybacks as a share of market value—-6.4%-1.6%-0.1%-0.0%-0.0%-0.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.8%-3.3%—
Operating income-9.6%8.0%-8.8%
Net income-14.6%-1.8%-9.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-36.6%-39.5%-44.5%—
Net margin-30.3%-36.6%-43.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-99.7-116.4-108.0-66.3-37.8-115.7-43.2-129.2-88.3-52.2
Price to sales27.438.542.831.743.129.435.5172.4——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.